Delivery Order SPE2DB20D2014-SPE2DB24FB69D
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order valued at $2,530.62 to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military treatment programs and...
- The Defense Logistics Agency (DLA) awarded a $17,973.50 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company AmerisourceBergen Corporation. The $7,213.29 award is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a specialty pharmaceutical product. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,741.62 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564605282 OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical product to the government. This delivery order contract is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corporation's Corporate Office Division a $7,256.75 firm-fixed-price delivery order contract for the pharmaceutical product OZEMPIC 1MG/0.75ML. This order was placed under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical supplies to DLA facilities...
- The Defense Logistics Agency (DLA) awarded a $1,916.65 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which enables the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
- The U.S. Department of Defense's Medical Supply Chain, also known as the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Delivery Order contract worth $2,902.70 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a prescription medication. This Delivery Order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,161.08 firm fixed price delivery order contract to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract has a performance period through February 2, 2024 and was not set aside for any small business categories. Amerisourcebergen Drug Corp serves as a prime contractor to DLA providing a wide range of pharmaceutical and medical supplies in support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,985.70 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, with a performance period through August 5, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the federal government, including the military, with multiple Indefinite Delivery Contracts...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,741.62, for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. This contract has a completion date of May 8, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA)...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB69DDelivery Order
The Defense Logistics Agency (DLA) awarded a $27,826.31 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, leverages its extensive supply chain network to efficiently fulfill government contracts, with a particular focus on serving the Department of Defense and Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.8k | 4/24/24 |